Osteoporosis & Fragility Fractures — Topic Test
9 questions · exam mode (answers revealed at the end). 18 min suggested.
A 68-year-old postmenopausal woman with severe osteoporosis and a recent vertebral fragility fracture is started on a drug that is a recombinant analogue of parathyroid hormone given as a daily subcutaneous injection. By what principal mechanism does this agent increase bone mass?
AInhibition of RANK ligand by a monoclonal antibody
BAnabolic stimulation of osteoblasts when given intermittently
CReduction of bone turnover by oestrogen-receptor agonism
DInhibition of osteoclastic bone resorption by binding hydroxyapatite